Fujikon Industrial Holdings Limited (HKG:0927)
0.7300
+0.0200 (2.82%)
Aug 1, 2025, 2:59 PM HKT
Revance Therapeutics Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -36.11 | 17.17 | 24.61 | -37.07 | 10.27 | Upgrade |
Depreciation & Amortization | 28.81 | 24.83 | 24.91 | 35.01 | 40.47 | Upgrade |
Other Amortization | 0.01 | 0.02 | 0.08 | 0.07 | - | Upgrade |
Loss (Gain) From Sale of Assets | -0.9 | -1.15 | -1.81 | -4.35 | -4 | Upgrade |
Asset Writedown & Restructuring Costs | 0.1 | 0.1 | 0.1 | -0.1 | - | Upgrade |
Loss (Gain) From Sale of Investments | - | 0.32 | -0.01 | 0.39 | 0.02 | Upgrade |
Provision & Write-off of Bad Debts | -0.03 | 0.14 | 0.02 | -0.11 | -5.19 | Upgrade |
Other Operating Activities | 43.15 | 59.3 | 13.1 | 12.25 | 0.72 | Upgrade |
Change in Accounts Receivable | 115.04 | -61.56 | -49.86 | -63.12 | 44.65 | Upgrade |
Change in Inventory | 21.05 | -36.41 | 43.59 | -59.97 | 50.54 | Upgrade |
Change in Accounts Payable | -21.44 | 17.28 | -0.63 | 23.62 | -14.85 | Upgrade |
Change in Unearned Revenue | -6.1 | 14.08 | 3.69 | -2.5 | -27.28 | Upgrade |
Change in Other Net Operating Assets | 2.98 | -3.81 | -0.13 | 8.97 | 9.79 | Upgrade |
Operating Cash Flow | 146.55 | 30.3 | 57.65 | -86.92 | 105.13 | Upgrade |
Operating Cash Flow Growth | 383.62% | -47.44% | - | - | -54.57% | Upgrade |
Capital Expenditures | -25.74 | -41.71 | -16.08 | -13.77 | -8.18 | Upgrade |
Sale of Property, Plant & Equipment | 0.31 | 1.35 | 3 | 0.28 | 0.5 | Upgrade |
Investment in Securities | -126.74 | 4.61 | - | - | - | Upgrade |
Other Investing Activities | 4.89 | 10.81 | 0.06 | 2.71 | 2.09 | Upgrade |
Investing Cash Flow | -147.28 | -24.95 | -13.03 | -10.78 | -5.59 | Upgrade |
Long-Term Debt Repaid | -7.38 | -7.51 | -6.64 | -7.69 | -7.79 | Upgrade |
Total Debt Repaid | -7.38 | -7.51 | -6.64 | -7.69 | -7.79 | Upgrade |
Net Debt Issued (Repaid) | -7.38 | -7.51 | -6.64 | -7.69 | -7.79 | Upgrade |
Common Dividends Paid | -34.07 | -34.07 | -21.29 | -17.03 | -21.29 | Upgrade |
Other Financing Activities | -46.95 | -0.33 | -14.99 | -0.22 | -14.92 | Upgrade |
Financing Cash Flow | -88.39 | -41.91 | -42.93 | -24.94 | -44 | Upgrade |
Foreign Exchange Rate Adjustments | 0.03 | -7.4 | -1.76 | 5.15 | 10.05 | Upgrade |
Net Cash Flow | -89.09 | -43.95 | -0.07 | -117.49 | 65.58 | Upgrade |
Free Cash Flow | 120.82 | -11.41 | 41.57 | -100.69 | 96.95 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -54.05% | Upgrade |
Free Cash Flow Margin | 13.05% | -1.15% | 3.83% | -11.46% | 10.88% | Upgrade |
Free Cash Flow Per Share | 0.28 | -0.03 | 0.10 | -0.24 | 0.23 | Upgrade |
Cash Interest Paid | 0.4 | 0.34 | 0.3 | 0.24 | 0.23 | Upgrade |
Cash Income Tax Paid | 20.64 | 10.43 | 14.78 | 0.54 | 12.11 | Upgrade |
Levered Free Cash Flow | 135.5 | -11.97 | 45.2 | -84.61 | 102.89 | Upgrade |
Unlevered Free Cash Flow | 135.75 | -11.76 | 45.39 | -84.46 | 103.04 | Upgrade |
Change in Net Working Capital | -122.01 | 19.1 | -3.77 | 87.33 | -42.07 | Upgrade |
Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.